Article
Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association - 1 Apr 2019
Zhang Zhuoya, Niu Lingying, Tang Xiaojun, Feng Ruihai, Yao Genhong, Chen Weiwei, Li Wenchao, Feng Xuebing, Chen Hongwei, Sun Lingyun
Abstract excerpt
BACKGROUND: Podocyte injury plays a pathogenic role in the development of lupus nephritis (LN). Mesenchymal stem cells (MSCs) have shown promising therapeutic potential for LN. However, whether MSCs can prevent podocyte injury in LN remains unknown. METHODS: Human umbilical cord-derived MSCs (UC-MSCs) were infused into lupus-prone B6.MRL-Faslpr (B6.lpr) mice to investigate the influences of UC-MSCs on podocyte...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
